Raul Vizcardo

Raul Vizcardo^*,1,2, 

S.M. Rafiqul Islam^*,1,2, 

Takuya Maeda^1,2, 

Naritaka Tamaoki^1,2, 

Meghan L. Good^1,2, 

Nicholas D. Klemen^1,2, 

Marta Bosch-Marce^1,2, 

Li Jia¹, 

Mikhael J. Kruhlak³, 

Nicholas P. Restifo^1,2 

¹Surgery Branch, National Cancer Institute, NIH, 

²Center for Cell-Based Therapy, National Cancer Institute, NIH, 

³Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, NIH 

Meghan L. Good^*,1,2, 

Raul Vizcardo^*,1,2, 

Takuya Maeda^1,2, 

Naritaka Tamaoki^1,2, 

Parisa Malekzadeh¹, 

Hiroshi Kawamoto³, 

Nicholas P. Restifo^1,2 

¹Surgery Branch, National Cancer Institute, NIH, 

²Center for Cell-Based Therapy, National Cancer Institute, NIH, 

³Laboratory of Immunology, Institute for Frontier Life and Medical Sciences, Kyoto University